Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated other comprehensive income	Accumulated deficit	Total
Balance at Beginning of period at Dec. 31, 2022	$ 19	$ 288,361	$ 150	$ (274,225)	$ 14,305
Balance at Beginning of period (in shares) at Dec. 31, 2022	19,165,027
Vesting of restricted stock units and exercise of stock options		101			101
Vesting of restricted stock units and exercise of stock options (in shares)	119,240
Issuance of common stock under the employee stock purchase plan		88			88
Issuance of common stock under the employee stock purchase plan (in shares)	10,602
Shares withheld for employee taxes		(285)			(285)
Shares withheld for employee taxes (in shares)	(26,481)
Foreign currency translation adjustment			(15)		(15)
Stock-based compensation expense		3,791			3,791
Sale of common stock, net of underwriting discounts, commissions and offering costs	$ 5	46,336			46,341
Sale of common stock, net of underwriting discounts, commissions and offering costs (in shares)	5,219,190
Net loss				(33,774)	(33,774)
Balance at Ending period at Sep. 30, 2023	$ 24	338,392	135	(307,999)	30,552
Balance at Ending period (in shares) at Sep. 30, 2023	24,487,578
Balance at Beginning of period at Jun. 30, 2023	$ 24	336,939	84	(297,042)	40,005
Balance at Beginning of period (in shares) at Jun. 30, 2023	24,475,504
Vesting of restricted stock units and exercise of stock options		1			1
Vesting of restricted stock units and exercise of stock options (in shares)	2,002
Issuance of common stock under the employee stock purchase plan		88			88
Issuance of common stock under the employee stock purchase plan (in shares)	10,602
Shares withheld for employee taxes		(5)			(5)
Shares withheld for employee taxes (in shares)	(530)
Foreign currency translation adjustment			51		51
Stock-based compensation expense		1,369			1,369
Net loss				(10,957)	(10,957)
Balance at Ending period at Sep. 30, 2023	$ 24	338,392	135	(307,999)	30,552
Balance at Ending period (in shares) at Sep. 30, 2023	24,487,578
Balance at Beginning of period at Dec. 31, 2023	$ 24	339,655	91	(320,889)	18,881
Balance at Beginning of period (in shares) at Dec. 31, 2023	24,494,675
Vesting of restricted stock units and exercise of stock options	$ 1	225			226
Vesting of restricted stock units and exercise of stock options (in shares)	217,267
Issuance of common stock under the employee stock purchase plan		281			281
Issuance of common stock under the employee stock purchase plan (in shares)	58,994
Shares withheld for employee taxes		(358)			(358)
Shares withheld for employee taxes (in shares)	(53,743)
Foreign currency translation adjustment			58		58
Stock-based compensation expense		3,273			3,273
Net loss				(28,633)	(28,633)
Balance at Ending period at Sep. 30, 2024	$ 25	343,076	149	(349,522)	(6,272)
Balance at Ending period (in shares) at Sep. 30, 2024	24,717,193
Balance at Beginning of period at Jun. 30, 2024	$ 25	341,897	98	(339,150)	2,870
Balance at Beginning of period (in shares) at Jun. 30, 2024	24,675,832
Vesting of restricted stock units and exercise of stock options (in shares)	14,702
Issuance of common stock under the employee stock purchase plan		117			117
Issuance of common stock under the employee stock purchase plan (in shares)	31,025
Shares withheld for employee taxes		(19)			(19)
Shares withheld for employee taxes (in shares)	(4,366)
Foreign currency translation adjustment			51		51
Stock-based compensation expense		1,081			1,081
Net loss				(10,372)	(10,372)
Balance at Ending period at Sep. 30, 2024	$ 25	$ 343,076	$ 149	$ (349,522)	$ (6,272)
Balance at Ending period (in shares) at Sep. 30, 2024	24,717,193